Loading...
XKRX
019170
Market cap270mUSD
Jul 10, Last price  
8,100.00KRW
1D
-1.01%
1Q
-25.33%
Jan 2017
32.27%
Name

Shinpoong Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:019170 chart
P/E
47.46
P/S
1.78
EPS
170.67
Div Yield, %
Shrs. gr., 5y
1.86%
Rev. gr., 5y
3.48%
Revenues
234.68b
+6.15%
165,922,224,000188,135,653,000217,255,761,000232,060,469,000229,693,072,190221,169,380,010215,962,840,330220,291,937,930195,950,486,360194,147,337,500184,998,400,350187,389,168,040189,721,696,060197,750,767,000189,237,234,930209,287,628,000200,228,582,500221,094,070,000234,680,653,000
Net income
8.83b
P
8,843,130,00012,051,001,00021,052,454,00021,734,263,00024,866,240,00014,377,490,0005,437,651,0003,349,617,3601,476,216,010-18,591,699,490904,889,0002,803,780,0005,323,827,0005,002,804,500-11,526,010,680-35,308,829,000-57,325,386,770-15,387,261,0008,825,118,000
CFO
17.25b
P
9,765,566,00023,570,779,0009,818,846,00011,357,006,00028,726,635,85030,792,490,39011,453,530,130-48,156,6909,890,504,09018,959,223,22010,148,039,89032,054,460,36019,350,539,80020,062,347,350-71,027,968,120-26,443,578,950-24,847,572,600-15,154,793,00017,253,672,000
Dividend
Dec 29, 2020100 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shinpoong Pharmaceutical Co., Ltd., a South Korean firm, specializes in the production and distribution of a broad spectrum of pharmaceutical goods. Its product offerings span various therapeutic categories, including cephalosporin and penicillin antibiotics, as well as a range of finished drug formulations. The company further supplies active pharmaceutical ingredients (APIs) and specialized medications like Pyramax, an anti-malarial treatment. Additionally, Shinpoong develops drugs for conditions such as hypercholesterolemia, knee osteoarthritis, shoulder periarthritis, and for preventing surgical adhesion, alongside its over-the-counter (OTC) products. With a notable international footprint, Shinpoong Pharmaceutical exports its remedies to approximately 50 countries globally. This company, established in 1962, is headquartered in Seoul, South Korea.
IPO date
Jan 20, 1990
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT